Pfizer to buy Array BioPharma in deal worth $11.4 billion

Pfizer said Monday it will pay $48 per share in cash for Array, whose product portfolio includes a treatment combination used for advanced skin cancer that is being tested in other cancers as well.

Array's share price has jumped 41 percent since late May and more than doubled so far this year. Pfizer's offer of $48 per share represents a premium of 62 percent to the stock's closing price of $29.59 on Friday.

One less competition for Pfizer and an excuse to raise prices for this drug.

Didn't they hear that biden has the cure for cancer but only if he is elected 😂

In other news 'Possible cancer cure found financially unfeasible - Pfizer forced to continue trillions of dollars worth of sales in ongoing treatment instead...' Big Pharma wins again....

Gee...... I wonder what the price of this new miracle drug will be? Your house Your career Your first born Your marriage I'm sure it will be whatever you can't afford.

Pfizer will make Array BioPharma close its doors soon, and those trials will disappear.

ReeseHussey

is this part of 'The right to try' ? that pres Trump sign 😌

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer to buy cancer drug developer Array Biopharma for $10.64 billionPfizer said on Monday it had agreed to acquire Array Biopharma for $10.64 billion, which will grant it access to its cancer drugs. Drugs are bad. Mmm’kay?
Source: CNBC - 🏆 12. / 72 Read more »

Pfizer to Buy Cancer Drug Maker Array BioPharma for $10.64 BillionPfizer agreed to buy Array BioPharma for $10.64 billion in cash, as the pharmaceutical company looks to expand its pipeline of cancer therapies.
Source: WSJ - 🏆 98. / 63 Read more »

Pfizer bolsters cancer portfolio with $10.64 billion deal for ArrayPfizer Inc on Monday struck a deal to buy Array Biopharma Inc for $10.64 billion... pfizer Hows the magellic [PB] liquid to be used AEs & Expect to see what success rate per 100K
Source: Reuters - 🏆 2. / 97 Read more »

Shares of cancer-therapy companies skyrocket after Pfizer acquisition newsShares of gene-therapy companies shot up on Monday after Pfizer Inc. announced it would acquire cancer drug maker Array BioPharma Inc. in a deal worth up to... What’s bitcoin doing if these are skyrocketing?
Source: MarketWatch - 🏆 3. / 97 Read more »